Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 1 19Phase 1/2 10Phase 2/3 2Phase 3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Leukemia 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 1Lymphoma 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Congenital Abnormalities 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 13Methotrexate 12Cytarabine 11Dexamethasone 10Vincristine 9Etoposide 7Radiotherapy 6Mercaptopurine 6Daunorubicin 6Asparaginase 6pegaspargase 5blinatumomab 5Dasatinib 5Prednisone 4Methylprednisolone 4Filgrastim 4Doxorubicin 4ruxolitinib 3N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3Idarubicin 3Granulocyte Colony-Stimulating Factor 3Drug Therapy 3Busulfan 3Antilymphocyte Serum 3venetoclax 2fludarabine phosphate 2fludarabine 2etoposide phosphate 2calaspargase pegol 2Thiotepa 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Clofarabine × Clear all
NCT03117751 2025-12-05

Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma

St. Jude Children's Research Hospital

Phase 2/3 Active not recruiting
790 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01228331 2024-12-11

Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL

Universitätsklinikum Hamburg-Eppendorf

Phase 2/3 Completed
745 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡